Signaling Pathways - Ca2 -ATPases - VEGFR3/FLT4 - Flk1 - Androgen Receptors
清除全部
- A8452 ODM-201中文名: 达洛鲁胺Target: Androgen ReceptorsSummary: 新一代雄激素受体抑制剂
- B6614 Thapsigargin1 Citation中文名: 毒胡萝卜素Target: Ca2 -ATPasesSummary: 肌质网状Ca2+-ATP酶抑制剂
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂
- A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
- A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂
- A2597 Brivanib (BMS-540215)中文名: 布立尼布Target: VEGFR|FGFR|Flk1Summary: VEGFR-2的ATP竞争性抑制剂
- A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体(Androgen receptor)拮抗剂
- A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂
- A3003 MDV3100 (Enzalutamide)12 Citation中文名: 恩杂鲁胺Target: Androgen ReceptorsSummary: 雄激素受体拮抗剂。